Which type of patients with asymptomatic peripheral arterial disease with an ABI score of less than 0.9, is it reasonable to offer antiplatelet and statin therapy to?

This is an important question. Unfortunately, there is no good evidence to help answer it. So what I am about to say is not evidence-based, but it is common sense. Since patients with PAD have an increased rate of MI, Stroke, and CV death, they should all receive maximum medical therapy. I believe t...

More information is needed. Why were ABIs obtained if the patient is asymptomatic? How old is the patient and what are the patient's CVD risk factors?

I agree that a statin is reasonable for most patients under age 75 with asymptomatic PAD. For those age 75 or older, shared decision-making would be...